CLASS II Drug recall · Reported 9 Aug 2023 · FDA Enforcement Report

midazolam in dextrose 5%, 50 mg /, (1 mg/mL) Syringe recalled

Central Admixture Pharmacy Services is recalling midazolam in dextrose 5%, 50 mg /, (1 mg/mL) Syringe, distributed nationwide in the US. The recall was initiated on 17 Jul 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 17-270666, Exp. 7/18/2023; 17-270879, Exp. 7/20/2023; 17-271669, Exp. 8/2/2023; 17-272287, Exp. 8/14/2023; 17-272366, Exp. 8/15/2023; 17-272991, Exp. 8/24/2023; 17-273512, Exp. 9/4/2023.
Quantity recalled621 syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1075-2023
FDA event ID
92752
Recalling firm
Central Admixture Pharmacy Services, San Diego, CA
Classification
Class II
Status
Terminated
Recall initiated
17 Jul 2023
FDA classified
3 Aug 2023
Reported
9 Aug 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

17 Jul 2023Recall initiated by company
3 Aug 2023Classified by FDA+17 days
9 Aug 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of assurance of sterility: Lack of validation data for sanitization cycles

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Which lots are affected?

Lot: 17-270666, Exp. 7/18/2023; 17-270879, Exp. 7/20/2023; 17-271669, Exp. 8/2/2023; 17-272287, Exp. 8/14/2023; 17-272366, Exp. 8/15/2023; 17-272991, Exp. 8/24/2023; 17-273512, Exp. 9/4/2023.

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

38 other products · FDA event 92752

This product is part of a recall event; the main page for the event is HYDROmorphone in 0.9% sodium chloride, 15 mg/, (0.5 mg/mL) Syringe recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIHYDROmorphone in 0.9% sodium chloride, 15 mg/, (0.5 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IImorphine in 0.9% sodium chloride, 125 mg/, (5 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL in 0.9% sodium chloride, 5000 mcg/, (20 mcg/mL) recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL, 1250 mcg/, (50 mcg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL, 5000 mcg/, (50 mcg/mL) recalled by Central Admixture PharmacyCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIHYDROmorphone added to 0.9% sodium chloride, 10 mg/, (0.2 mg/mL) recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL, 2500 mcg/, (50 mcg/mL) recalled by Central Admixture PharmacyCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIPHENYLephrine in 0.9 sodium chloride, 800 mcg /, (80 mcg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIsuccinylcholine, 200 mg/, (20 mg/mL) syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IImorphine in 0.9% sodium chloride, 1 mg/, (1 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL in 0.9% sodium chloride, 10 mcg/, (10 mcg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IImorphine in 0.9% Sodium Chloride, 50 mg/ (1mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL 2 mcg/mL and bupivacaine 0.0625% PF recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL in dextrose 5%, 300 mcg/, (10 mcg/mL) syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL in 0.9% sodium chloride, 1000 mcg/, (10 mcg/mL) recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIvecuronium, 10 mg/, (1 mg/mL) syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIPHENYLephrine in 0.9% sodium chloride, 1000 mcg recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIHYDROmorphone in dextrose 5%, 3 mg/, (0.1 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL in 0.9% sodium chloride, 2500 mcg/, (10 mcg/mL) recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIHYDROmorphone in 0.9% sodium chloride, 10 mg/, (0.2 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIlidocaine 2%, 100 mg /, (20 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL 2 mcg/mL and bupivacaine 0.125% PF recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIHYDROmorphone in 0.9% sodium chloride, 30 mg/, (1 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIHYDROmorphone in Dextrose 5%, 0.5 mg/ (0.1 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL, 250 mcg/, (50 mcg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL 2 mcg/mL and bupivacaine 0.125% PF recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIHYDROmorphone in 0.9% sodium chloride, 6 mg/, (0.2 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIPHENYLephrine in 0.9 sodium chloride, 400 mcg /, (40 mcg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIketamine in 0.9% sodium chloride, 50 mg/ (10mg/mL) syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IImorphine in 0.9% sodium chloride, 30 mg/, (1 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIrocuronium, 50 mg /, (10 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL in 0.9% sodium chloride, 10 mcg/, (10 mcg/mL) syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL, 100 mcg/, (50 mcg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIePHEDrine in 0.9% sodium chloride, 50 mg /, (10 mg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL in 0.9% sodium chloride, 100 mcg/, (10 mcg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL, 2500 mcg/, (50 mcg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide
CLASS IIfentaNYL in 0.9% sodium chloride, 500 mcg/, (10 mcg/mL) Syringe recalledCentral Admixture Pharmacy ServicesSterilityNationwide

More recalls from Central Admixture Pharmacy Services

All 347

Other Midazolam recalls

All 36